Jetze advises on patent matters in the field of life sciences. His work includes the drafting, and worldwide prosecution, of patent applications relating to biotechnological inventions. He further assesses validity, scope of protection and infringement of patents, and advises in contentious patent proceedings.

In his capacity as European Patent Litigator, Jetze is allowed to act as UPC representative.

Working experience

• Patent attorney, V.O. (2014-present)

Education

• MSc in Molecular Biology & Biotechnology, University of Groningen (cum laude)
• LLM in Law, University of Groningen, University of Groningen (cum laude)

Directories

• “Recently, pharmaceutical litigation by patent attorneys such as Jetze Beeksma and Martin Klok for research-based industry has dominated more than in previous years. Both partners are stars in the Dutch patent scene” (JUVE Patent 2024)
• Recommended individual (JUVE Patent 2020, 2021, 2022, 2023, 2024)
• “The life sciences group had an exceptionally strong year thanks to the meteoric rise of Jetze Beeksma, who was lead counsel for the technical aspects of Moderna’s litigation against Pfizer and BioNTech in the Dutch proceedings over mRNA vaccines” (JUVE Patent 2023)
• “We appreciate the team’s high-quality work. They are very responsive and, most of all, easy to work with (Jetze Beeksma)” (Managing IP, 2023)
• “He is doing a great job on the originator side” (JUVE Patent 2022)
• Recognized as ‘Rising Star’ (2020, 2021, 2022, 2023, 2024) by Managing IP
• “Very good in pharmaceuticals, definitely a younger patent attorney to have an eye on in the future” (JUVE Patent 2020)

Languages

• Dutch
• English